CORONA · Ratios · TradingHolo

Markets › India › NSE › CORONA

Corona Remedies Ltd

NSE:CORONAHealth TechnologyNSE:NIFTY_IPO

₹2,010.00+0.30%At closeAt close · Mon 19 Oct · ≈ AED 77.66 · Market cap $1.29B · Next earnings Wed 2 Dec

🔔 Alert▶ Test a strategy

Ratio	FY2021	FY2021	FY2022	FY2023	FY2024	FY2025	Trend	YoY
Gross margin	29.3%	29.3%	38.3%	39.0%	41.8%	42.9%		+1.1 pts
Operating margin	—	−0.3%	12.2%	13.6%	17.1%	18.4%		+1.3 pts
Net margin	−0.1%	−0.1%	9.6%	8.9%	12.5%	13.2%		+0.7 pts
EBITDA margin	3.1%	3.1%	14.4%	16.4%	20.2%	21.1%		+0.9 pts
Return on equity	—	−0.1%	20.8%	18.8%	24.6%	24.8%		+0.1 pts
Return on assets	−0.1%	−0.1%	14.0%	10.6%	15.7%	15.0%		−0.7 pts
Return on capital employed	—	−0.4%	22.8%	22.0%	28.6%	29.4%		+0.8 pts
Debt / equity	—	0.2×	0.1×	0.3×	0.1×	0.2×		+55.2%
Debt / assets	10.9%	10.9%	4.6%	18.7%	9.0%	13.3%		+4.3 pts
Interest coverage	0.0×	−0.4×	25.3×	9.6×	19.3×	36.9×		+91.7%
Current ratio	—	1.9×	2.1×	1.3×	1.4×	1.0×		−31.8%
Quick ratio	—	1.4×	1.3×	0.8×	0.8×	0.6×		−27.7%
Cash ratio	—	0.1×	0.1×	0.0×	0.0×	0.0×		+155.0%
Asset turnover	1.2×	1.2×	1.5×	1.2×	1.3×	1.1×		−9.6%
Inventory turnover	—	5.7×	4.8×	5.9×	5.1×	6.2×		+22.8%
Receivables turnover	—	8.2×	10.1×	10.1×	9.8×	9.6×		−2.5%
Dividend payout	—	−1,748.5%	8.2%	18.7%	15.1%	24.2%		+9.0 pts

Margins, returns, leverage and liquidityUpdated Tue 31 Mar ·

ⓘ